Home

About Us

Pharma-Free CME

Resources by Topic

Resources by Type

Teaching Tools

Drug Industry

Contact Us

RSS NEWS FEED

Home

PharmedOut is an independent, publicly funded project that empowers physicians to identify and counter inappropriate pharmaceutical promotion practices. PharmedOut promotes evidence-based medicine by providing news, resources, and links to pharma-free CME courses.

Pharma-Free CME

More than 200 free web-based CME credits are available without cost.

Resources by Topic

Drug promotion, drug information, evidence-based
medicine, docs and pharma, industry-sponsored research, conflict of interest, direct-to-consumer advertising, drug reps, and other topics.

Resources by Type

Articles, reports, slide shows, databases, subscribables, and links to other organizations and websites.

Teaching Tools

No Drug Reps Certificate, Drug Ad Bingo, and other materials for educators.

---

PharmedOut Publications

PharmedOut in the Media

News Archive

How You Can Help

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---

News

Vermont Acts to Make Drug Makers’ Gifts Public
Free meals banned NYT

---

Physician Found Money, Acclaim Seductive
Former thought leader repents Journal Sentinel

---

Doctor Falsified Study on Injured GIs
Infuse success rate questioned NYT (read update)

---

Top 15 Big Pharma Paychecks of 2008
J&J CEO tops list at $29.4M Fierce Pharma

---

29 Percent of Cancer Studies Report Conflict of Interest
Industry funding common Science Daily (read press release; read study abstract)

---

Merck Paid for Medical ‘Journal’
Elsevier Published 6 Fake Journals NYT (read The Scientist)

---

The Next Phase in Industry-Funded Medical Education
“Product theater” at APA meeting Carlat Psych Blog (read more)

---

A Celebrity Patient's Backing Turns Sour for Drug Company
Controversy surrounds Abilify WSJ (read commentary)

---

IOM Says New Rules Needed
Limiting drug company influence over doctors AP (read report)

---

Commentary

New Drugs Have Allure, Not Track Record
Older drugs can be more effective NYT (read more)

---

Swine Flu
Who will bring home the bacon? Unsilent Generation

---

JAMA COI Controversy Continued
Study protocol changed after NIH approved BMJ Rapid Response

---

Click HERE to read the entire news archives